Patent · US Expired

HIV-2 virus variants

US5637455A · kind A · utility

3Cited by

1References

14Claims

0Family size

Assignees

QIAGEN GmbH · DE
CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS · DE

Inventors

Karsten Henco · Erkrath, DE
Hagen von Briesen · Idstein, DE
Andreas Immelmann · Düsseldorf, DE
Herbert Kuhnel · Egelsbach, DE
Ursula Dietrich · Eschborn, DE
Helga Rubsamen-Waigmann · Bad Soden, DE
Michalina Adamski · Frankfurt, DE

Key dates

Filing date	Dec 14, 1994
Grant date	Jun 10, 1997
Priority date	—
Expiry date	Dec 14, 2014

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/826
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

HIV-2 virus variants, namely virus HIV D194 and virus HIV D205, which can be cloned from the corresponding virus isolate HIV D194 (ECACC V 87122303) or from the infected cell line HUT 194 (ECACC V 87122306) or from the virus isolate HIV D205 (ECACC V 87122304), respectively, and their RNA or RNA-fragments and DNA and DNA-fragments derived therefrom and/or proteins and the use thereof for diagnostics and therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.